Literature DB >> 27751915

Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells.

Schammim Ray Amith1, Krista Marie Vincent2, Jodi Marie Wilkinson3, Lynne Marie Postovit4, Larry Fliegel5.   

Abstract

Mounting evidence supports a major role for the Na+/H+ exchanger NHE1 in cancer progression and metastasis. NHE1 is hyperactive at the onset of oncogenic transformation, resulting in intracellular alkalinization and extracellular microenvironmental acidification. These conditions promote invasion and facilitate metastasis. However, the signal pathways governing the regulation of exchanger activity are still unclear. This is especially important in the aggressively metastatic, triple-negative basal breast cancer subtype. We used affinity chromatography followed by mass spectrometry to identify novel and putative interaction partners of NHE1 in MDA-MB-231 triple-negative breast cancer cells. NHE1 associated with several types of proteins including cytoskeletal proteins and chaperones. We validated protein interactions by co-immunoprecipitation for: 14-3-3, AKT, α-enolase, CHP1, HSP70 and HSP90. Additionally, we used The Cancer Genome Atlas (TCGA) to study NHE1 gene expression in primary patient breast tumours versus adjacent normal tissue. NHE1 expression was elevated in breast tumour samples and, when broken down by breast cancer subtype, NHE1 gene expression was significantly lower in tumours of the basal subtype compared to luminal and HER2+ subtypes. Reverse phase protein array (RPPA) analysis showed that NHE1 expression positively correlated with p90RSK expression in basal, but not luminal, primary tumours. Other proteins were negatively correlated with NHE1 expression in basal breast cancer tumours. Taken together, our data provides the first insight into the signalling molecules that form the NHE1 interactome in triple-negative breast cancer cells. These results will focus our search for novel targeted therapies. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  14-3-3; NHE1; Signal scaffold; Triple-negative breast cancer; p90(RSK)

Mesh:

Substances:

Year:  2016        PMID: 27751915     DOI: 10.1016/j.cellsig.2016.10.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

1.  Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.

Authors:  Larry Fliegel
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 2.  Sodium homeostasis in the tumour microenvironment.

Authors:  Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-07-23       Impact factor: 10.680

3.  Decoding empagliflozin's molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence.

Authors:  Antoni Bayes-Genis; Oriol Iborra-Egea; Giosafat Spitaleri; Mar Domingo; Elena Revuelta-López; Pau Codina; Germán Cediel; Evelyn Santiago-Vacas; Adriana Cserkóová; Domingo Pascual-Figal; Julio Núñez; Josep Lupón
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 4.  Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX.

Authors:  Paul C McDonald; Mridula Swayampakula; Shoukat Dedhar
Journal:  Metabolites       Date:  2018-03-08

5.  The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion.

Authors:  M Swayampakula; P C McDonald; M Vallejo; E Coyaud; S C Chafe; A Westerback; G Venkateswaran; J Shankar; G Gao; E M N Laurent; Y Lou; K L Bennewith; C T Supuran; I R Nabi; B Raught; S Dedhar
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

6.  Disruption of pH Dynamics Suppresses Proliferation and Potentiates Doxorubicin Cytotoxicity in Breast Cancer Cells.

Authors:  Diana Tavares-Valente; Bárbara Sousa; Fernando Schmitt; Fátima Baltazar; Odília Queirós
Journal:  Pharmaceutics       Date:  2021-02-09       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.